Report Detail
COVID-19 Impact on Global Adult and Pediatric Vaccines Market Size, Status and Forecast 2020-2026
- RnM3985263 |
- 03 June, 2020 |
- Global |
- 96 Pages |
- QYResearch |
- Pharma & Healthcare
A vaccine is a biological preparation that provides active acquired immunity to a particular disease.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Adult and Pediatric Vaccines market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Adult and Pediatric Vaccines industry.
Based on our recent survey, we have several different scenarios about the Adult and Pediatric Vaccines YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Adult and Pediatric Vaccines will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Adult and Pediatric Vaccines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Adult and Pediatric Vaccines market in terms of revenue.
Players, stakeholders, and other participants in the global Adult and Pediatric Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Adult and Pediatric Vaccines market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Adult and Pediatric Vaccines market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Adult and Pediatric Vaccines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Adult and Pediatric Vaccines market.
The following players are covered in this report:
GlaxoSmithKline
Sanofi
Merck
Novartis
Pfizer
AstraZeneca
Johnson and Johnson
Takeda Pharmaceutical
Bavarian Nordic
LG Life Sciences
Sinovac Biotech
Adult and Pediatric Vaccines Breakdown Data by Type
Adult Vaccines
Pediatric Vaccines
Adult and Pediatric Vaccines Breakdown Data by Application
Hospitals
Medical Care Centers
Others
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered: Ranking by Adult and Pediatric Vaccines Revenue
- 1.4 Market Analysis by Type
- 1.4.1 Global Adult and Pediatric Vaccines Market Size Growth Rate by Type: 2020 VS 2026
- 1.4.2 Adult Vaccines
- 1.4.3 Pediatric Vaccines
- 1.5 Market by Application
- 1.5.1 Global Adult and Pediatric Vaccines Market Share by Application: 2020 VS 2026
- 1.5.2 Hospitals
- 1.5.3 Medical Care Centers
- 1.5.4 Others
- 1.6 Coronavirus Disease 2019 (Covid-19): Adult and Pediatric Vaccines Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Adult and Pediatric Vaccines Industry
- 1.6.1.1 Adult and Pediatric Vaccines Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Adult and Pediatric Vaccines Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Adult and Pediatric Vaccines Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Adult and Pediatric Vaccines Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Global Growth Trends by Regions
- 2.1 Adult and Pediatric Vaccines Market Perspective (2015-2026)
- 2.2 Adult and Pediatric Vaccines Growth Trends by Regions
- 2.2.1 Adult and Pediatric Vaccines Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 Adult and Pediatric Vaccines Historic Market Share by Regions (2015-2020)
- 2.2.3 Adult and Pediatric Vaccines Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
- 2.3.5 Adult and Pediatric Vaccines Market Growth Strategy
- 2.3.6 Primary Interviews with Key Adult and Pediatric Vaccines Players (Opinion Leaders)
3 Competition Landscape by Key Players
- 3.1 Global Top Adult and Pediatric Vaccines Players by Market Size
- 3.1.1 Global Top Adult and Pediatric Vaccines Players by Revenue (2015-2020)
- 3.1.2 Global Adult and Pediatric Vaccines Revenue Market Share by Players (2015-2020)
- 3.1.3 Global Adult and Pediatric Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.2 Global Adult and Pediatric Vaccines Market Concentration Ratio
- 3.2.1 Global Adult and Pediatric Vaccines Market Concentration Ratio (CR5 and HHI)
- 3.2.2 Global Top 10 and Top 5 Companies by Adult and Pediatric Vaccines Revenue in 2019
- 3.3 Adult and Pediatric Vaccines Key Players Head office and Area Served
- 3.4 Key Players Adult and Pediatric Vaccines Product Solution and Service
- 3.5 Date of Enter into Adult and Pediatric Vaccines Market
- 3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Adult and Pediatric Vaccines Historic Market Size by Type (2015-2020)
- 4.2 Global Adult and Pediatric Vaccines Forecasted Market Size by Type (2021-2026)
5 Adult and Pediatric Vaccines Breakdown Data by Application (2015-2026)
- 5.1 Global Adult and Pediatric Vaccines Market Size by Application (2015-2020)
- 5.2 Global Adult and Pediatric Vaccines Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America Adult and Pediatric Vaccines Market Size (2015-2020)
- 6.2 Adult and Pediatric Vaccines Key Players in North America (2019-2020)
- 6.3 North America Adult and Pediatric Vaccines Market Size by Type (2015-2020)
- 6.4 North America Adult and Pediatric Vaccines Market Size by Application (2015-2020)
7 Europe
- 7.1 Europe Adult and Pediatric Vaccines Market Size (2015-2020)
- 7.2 Adult and Pediatric Vaccines Key Players in Europe (2019-2020)
- 7.3 Europe Adult and Pediatric Vaccines Market Size by Type (2015-2020)
- 7.4 Europe Adult and Pediatric Vaccines Market Size by Application (2015-2020)
8 China
- 8.1 China Adult and Pediatric Vaccines Market Size (2015-2020)
- 8.2 Adult and Pediatric Vaccines Key Players in China (2019-2020)
- 8.3 China Adult and Pediatric Vaccines Market Size by Type (2015-2020)
- 8.4 China Adult and Pediatric Vaccines Market Size by Application (2015-2020)
9 Japan
- 9.1 Japan Adult and Pediatric Vaccines Market Size (2015-2020)
- 9.2 Adult and Pediatric Vaccines Key Players in Japan (2019-2020)
- 9.3 Japan Adult and Pediatric Vaccines Market Size by Type (2015-2020)
- 9.4 Japan Adult and Pediatric Vaccines Market Size by Application (2015-2020)
10 Southeast Asia
- 10.1 Southeast Asia Adult and Pediatric Vaccines Market Size (2015-2020)
- 10.2 Adult and Pediatric Vaccines Key Players in Southeast Asia (2019-2020)
- 10.3 Southeast Asia Adult and Pediatric Vaccines Market Size by Type (2015-2020)
- 10.4 Southeast Asia Adult and Pediatric Vaccines Market Size by Application (2015-2020)
11 India
- 11.1 India Adult and Pediatric Vaccines Market Size (2015-2020)
- 11.2 Adult and Pediatric Vaccines Key Players in India (2019-2020)
- 11.3 India Adult and Pediatric Vaccines Market Size by Type (2015-2020)
- 11.4 India Adult and Pediatric Vaccines Market Size by Application (2015-2020)
12 Central & South America
- 12.1 Central & South America Adult and Pediatric Vaccines Market Size (2015-2020)
- 12.2 Adult and Pediatric Vaccines Key Players in Central & South America (2019-2020)
- 12.3 Central & South America Adult and Pediatric Vaccines Market Size by Type (2015-2020)
- 12.4 Central & South America Adult and Pediatric Vaccines Market Size by Application (2015-2020)
13 Key Players Profiles
- 13.1 GlaxoSmithKline
- 13.1.1 GlaxoSmithKline Company Details
- 13.1.2 GlaxoSmithKline Business Overview and Its Total Revenue
- 13.1.3 GlaxoSmithKline Adult and Pediatric Vaccines Introduction
- 13.1.4 GlaxoSmithKline Revenue in Adult and Pediatric Vaccines Business (2015-2020))
- 13.1.5 GlaxoSmithKline Recent Development
- 13.2 Sanofi
- 13.2.1 Sanofi Company Details
- 13.2.2 Sanofi Business Overview and Its Total Revenue
- 13.2.3 Sanofi Adult and Pediatric Vaccines Introduction
- 13.2.4 Sanofi Revenue in Adult and Pediatric Vaccines Business (2015-2020)
- 13.2.5 Sanofi Recent Development
- 13.3 Merck
- 13.3.1 Merck Company Details
- 13.3.2 Merck Business Overview and Its Total Revenue
- 13.3.3 Merck Adult and Pediatric Vaccines Introduction
- 13.3.4 Merck Revenue in Adult and Pediatric Vaccines Business (2015-2020)
- 13.3.5 Merck Recent Development
- 13.4 Novartis
- 13.4.1 Novartis Company Details
- 13.4.2 Novartis Business Overview and Its Total Revenue
- 13.4.3 Novartis Adult and Pediatric Vaccines Introduction
- 13.4.4 Novartis Revenue in Adult and Pediatric Vaccines Business (2015-2020)
- 13.4.5 Novartis Recent Development
- 13.5 Pfizer
- 13.5.1 Pfizer Company Details
- 13.5.2 Pfizer Business Overview and Its Total Revenue
- 13.5.3 Pfizer Adult and Pediatric Vaccines Introduction
- 13.5.4 Pfizer Revenue in Adult and Pediatric Vaccines Business (2015-2020)
- 13.5.5 Pfizer Recent Development
- 13.6 AstraZeneca
- 13.6.1 AstraZeneca Company Details
- 13.6.2 AstraZeneca Business Overview and Its Total Revenue
- 13.6.3 AstraZeneca Adult and Pediatric Vaccines Introduction
- 13.6.4 AstraZeneca Revenue in Adult and Pediatric Vaccines Business (2015-2020)
- 13.6.5 AstraZeneca Recent Development
- 13.7 Johnson and Johnson
- 13.7.1 Johnson and Johnson Company Details
- 13.7.2 Johnson and Johnson Business Overview and Its Total Revenue
- 13.7.3 Johnson and Johnson Adult and Pediatric Vaccines Introduction
- 13.7.4 Johnson and Johnson Revenue in Adult and Pediatric Vaccines Business (2015-2020)
- 13.7.5 Johnson and Johnson Recent Development
- 13.8 Takeda Pharmaceutical
- 13.8.1 Takeda Pharmaceutical Company Details
- 13.8.2 Takeda Pharmaceutical Business Overview and Its Total Revenue
- 13.8.3 Takeda Pharmaceutical Adult and Pediatric Vaccines Introduction
- 13.8.4 Takeda Pharmaceutical Revenue in Adult and Pediatric Vaccines Business (2015-2020)
- 13.8.5 Takeda Pharmaceutical Recent Development
- 13.9 Bavarian Nordic
- 13.9.1 Bavarian Nordic Company Details
- 13.9.2 Bavarian Nordic Business Overview and Its Total Revenue
- 13.9.3 Bavarian Nordic Adult and Pediatric Vaccines Introduction
- 13.9.4 Bavarian Nordic Revenue in Adult and Pediatric Vaccines Business (2015-2020)
- 13.9.5 Bavarian Nordic Recent Development
- 13.10 LG Life Sciences
- 13.10.1 LG Life Sciences Company Details
- 13.10.2 LG Life Sciences Business Overview and Its Total Revenue
- 13.10.3 LG Life Sciences Adult and Pediatric Vaccines Introduction
- 13.10.4 LG Life Sciences Revenue in Adult and Pediatric Vaccines Business (2015-2020)
- 13.10.5 LG Life Sciences Recent Development
- 13.11 Sinovac Biotech
- 10.11.1 Sinovac Biotech Company Details
- 10.11.2 Sinovac Biotech Business Overview and Its Total Revenue
- 10.11.3 Sinovac Biotech Adult and Pediatric Vaccines Introduction
- 10.11.4 Sinovac Biotech Revenue in Adult and Pediatric Vaccines Business (2015-2020)
- 10.11.5 Sinovac Biotech Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Adult and Pediatric Vaccines. Industry analysis & Market Report on COVID-19 Impact on Global Adult and Pediatric Vaccines is a syndicated market report, published as COVID-19 Impact on Global Adult and Pediatric Vaccines Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Adult and Pediatric Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
